EUVIMEDEUVIMED entdecken
Crossref

Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction

Anderson Oliveira Estevan, Ana Luísa Guedes de Franca e Silva, Salvador Rassi, Aguinaldo Figueiredo de Freitas, Salvador Rassi

ABC Heart Fail Cardiomyop · 31.12.2025 · 5 (4)

DOI: 10.36660/abchf.20250018i ↗

Kurz gefasst

Fachartikel in der Zeitschrift ABC Heart Fail Cardiomyop, erschienen am 31.12.2025. Verfasst von Anderson Oliveira Estevan und 4 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Estevan, A. O., Silva, A. L. G. D. F. E., Rassi, S., Freitas, A. F. D., & Rassi, S. (2025). Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction. ABC Heart Fail Cardiomyop, 5(4). https://doi.org/10.36660/abchf.20250018i

Vancouver

Estevan AO, Silva ALGDFE, Rassi S, Freitas AFD, Rassi S. Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction. ABC Heart Fail Cardiomyop. 2025;5(4). doi:10.36660/abchf.20250018i

BibTeX
@article{Estevan2025,
  author = {Estevan, Anderson Oliveira and Silva, Ana Luísa Guedes de Franca e and Rassi, Salvador and Freitas, Aguinaldo Figueiredo de and Rassi, Salvador},
  title = {Prevalence and Clinical Determinants of Optimized Pharmacological Therapy in Heart Failure with Reduced Ejection Fraction},
  journal = {ABC Heart Fail Cardiomyop},
  year = {2025},
  volume = {5},
  number = {4},
  doi = {10.36660/abchf.20250018i}
}
Kostenlos starten →